Low Level Light Therapy & Skin Pigmentation

Who May Qualify: - Ability to read and understand the study willing to sign a consent form in English - Age 18 years or older at enrollment - Individuals with MGD based on one or more of the following clinical signs/symptoms, e.g., meibum quality score of 1-3 (Bron et al.), meibography score of 1, 2, or 3 on the Pult Meiboscale, non-invasive 1st tear break up time of 10 seconds or less, or an Ocular Surface Disease Index (OSDI) score greater than 12 points. Who Should NOT Join This Trial: - Active anterior segment pathology (e.g., bacterial conjunctivitis, microbial keratitis) - History of systemic disease associated with aqueous-deficient dry eye disease (e.g., Sjogren's syndrome) - History of corneal surgery, refractive surgery, or eyelid surgery within 6 months - History of corneal ectasia (e.g. keratoconus, Pellucid marginal degeneration) - History of ocular trauma within 6 months - History of LipiFlow, iLux, Meiboflow, IPL or LLLT within the last 12 months - Habitual use of photosensitizing medications within the last 30 days - Pregnant and/or lactating females, by self-report - Pigmented lesions, tattoos, or skin cancer in the periocular region - Unwilling to have eyes photographed or video recorded Always talk to your doctor about whether this trial is right for you.